Yingjia Ni - Publications

Affiliations: 
2012-2018 Biological Sciences University of Notre Dame, Notre Dame, IN, United States 

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Li D, Wang C, Ni Y, Liu Y, Wang W, Zhang S, Chang HC, Senapati S. Development of a Multi-target Protein Biomarker Assay for Circulating Tumor Cells. Methods in Molecular Biology (Clifton, N.J.). 2394: 3-18. PMID 35094318 DOI: 10.1007/978-1-0716-1811-0_1  0.563
2020 Zhang W, Zhang K, Yao Y, Liu Y, Ni Y, Liao C, Tu Z, Qiu Y, Wang D, Chen D, Qiang L, Li Z, Jiang S. Dual nicotinamide phosphoribosyltransferase and epidermal growth factor receptor inhibitors for the treatment of cancer. European Journal of Medicinal Chemistry. 113022. PMID 33239261 DOI: 10.1016/j.ejmech.2020.113022  0.341
2020 Zhang Q, Yang Z, Ni Y, Bai H, Han Q, Yi Z, Yi X, Agbana YL, Kuang Y, Zhu Y. NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC. Cancer Cell International. 20: 483. PMID 33041664 DOI: 10.1186/s12935-020-01576-2  0.305
2017 Schmidt KR, Ni Y, Zhang S. Abstract LB-321: Cytoplasmic DEDD promotes G1- to S-phase cell cycle transition Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-321  0.614
2015 Ni Y, Zhang S. Erbb4 Signaling: an overlooked backup system? Cell Cycle (Georgetown, Tex.). 14: 1623. PMID 25945734 DOI: 10.1080/15384101.2015.1032653  0.695
Show low-probability matches.